Influence of delays to nonemergent colon cancer surgery on operative mortality, disease-specific survival and overall survival

Canadian Journal of Surgery

Volumn 52, Issue 4, 2009, Pages

  Simunovic, Marko ^a,b   Rempel, Eddy ^a   Thériault, Marc Erick ^c   Baxter, Nancy N ^d   Virnig, Beth A ^e   Meropol, Neal J ^f   Levine, Mark N ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b JURAVINSKI CANCER CENTRE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e UNIVERSITY OF MINNESOTA   (United States)

^f FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 69049093896     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Risberg T, Sorbye S, Norum J, et al. Diagnostic delay causes more psychological distress in female than in male breast cancer patients. Anticancer Res 1996;16:995-999 (Pubitemid 26182046)
2. Benedict S, Williams RD, Baron PL. Recalled anxiety: from discovery to diagnosis of a benign breast mass. Oncol Nurs Forum 1994;21: 1723-1727
3. Gray RE, Fitch M, Phillips C, et al. Presurgery experiences of prostate cancer patients and their spouses. Cancer Pract 1999;7:130-135
4. Christensen ED, Harvald T, Jendresen M, et al. The impact of delayed diagnosis of lung cancer on the stage at the time of operation. Eur J Cardiothorac Surg 1997;12:880-884
5. Richards MA, Smith P, Ramirez AJ, et al. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 1999;79:858-864
6. Roncoroni L, Pietra N, Violi V, et al. Delay in the diagnosis and out-come of colorectal cancer: a prospective study. Eur J Surg Oncol 1999;25:173-178
7. Huang J, Barbera L, Brouwers M, et al. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 2003;21:555-563
8. Tannock I, Hill RP, editors. The basic science of oncology. 3rd ed. New York (NY): McGraw Hill; 1998.
9. Overview of the SEER Program. In: Surveillance Epidemiology and End Results [SEER website]. Available: http://seer.cancer.gov/about/(accessed 2009 Jun. 9).
10. Warren JL, Klabunde CN, Schrag D, et al. Overview of the SEER- Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002;40(8 Suppl):IV-3-18.
11. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics 2002. CA Cancer J Clin 2005; 55:74-108.
12. Ries LAG, Eisner MP, Kosary CL, et al., eds. SEER Cancer Statistics Review, 1975-2002. In: Surveillance Epidemiology and End Results [SEER website]. Available: http://seer.cancer.gov/csr/1975-2002/ (accessed 2009 Jun. 9).
13. Cancer Care Ontario. Insight on cancer: news and information on colorectal cancer and screening in Ontario. Toronto (ON): Canadian Cancer Society (Ontario Division); 2004. Available: www.cancer.ca/ontario/publications/ od-insight%20on%20cancer/∼/media/CCS/Ontario/Files%20 List/ English%20files%20heading/Library%20PDFs%20-%20English/Insight%20on%20Cancer%20- %20Volume%207.ashx (accessed 2009 Jun. 9).
14. Potosky AL, Riley GF, Lubitz JD, et al. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 1993;31:732-748
15. Virnig BA, Warren JL, Cooper GS, et al. Studying radiation therapy using SEER-Medicare-linked data. Med Care 2002;40(8 Suppl):IV- 49-54.
16. Simunovic M, Thériault M, Paszat L, et al. Using administrative databases to measure waiting times for patients undergoing major cancer surgery in Ontario, 1993-2000. Can J Surg 2005;48:137-142
17. Hong D, Tandan VR, Goldsmith CH, et al.; Evidence-Based Surgery Working Group. Users' guide to the surgical literature: how to use an article reporting population-based volume-outcome relationships in surgery. Can J Surg2002;45:109-115
18. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-619
19. Warren JL, Harlan LC, Fahey A, et al. Utility of the SEER- Medicare data to identify chemotherapy use. Med Care 2002;40(8 Suppl):IV-55-61.
20. Ball JK, Elixhauser A. Treatment differences between blacks and whites with colorectal cancer. Med Care 1996;34:970-984
21. Cooper GS, Yuan Z, Landefeld CS, et al. Surgery for colorectal cancer: race-related differences in rates and survival among Medicare beneficiaries. Am J Public Health 1996;86:582-586
22. Schrag D, Cramer LD, Bach PB, et al. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 2001;93:850-857
23. Mayo NE, Scott SC, Shen N, et al. Waiting time for breast cancer surgery in Quebec. CMAJ 2001;164:1133-1138
24. Hodgson D, Przybysz R, Bhamani A, et al. Cancer surgery. In: Tu JV, Pinfold SP, McColgan P, et al., editors. Access to health services in Ontario. 2nd ed. Toronto (ON): Institute for Clinical Evaluative Sciences; 2006. Available from: www.ices.on.ca/webpage.cfm?site-id=1&org-id=67&morg-id= 0&gsec-id=0&item-id=2862&type= atlas (accessed 2009 Jun. 9).
25. Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002;97:72-81.
26. Canadian Society of Surgical Oncology. Position statement. In: CSSO (Society website). Available: www.cos.ca/csso/ (accessed 2009 Jun. 9).